If your California med spa or aesthetic platform still uses a percentage-based MSO fee, this is no longer something to clean up later. It is a decision-point issue now.
As the California 2026 summary of SB 351 and AB 1415 makes clear, these new rules directly affect physician-owned med spas, aesthetic practices using MSO structures, private equity-backed platforms, and any entity with contractual influence over clinical decisions. The law is enacted and in effect as of January 1, 2026.
That does not mean every California MSO is automatically illegal. It does mean the room for aggressive control, revenue-based compensation, and weak separation between business operations and medical authority has narrowed significantly.
SB 351 Is Going After Control, Not Just Ownership
California’s shift is bigger than a simple ownership conversation. The real focus is who actually influences the clinical side of the business.
According to the California regulatory summary of SB 351, private equity firms and hedge funds may not control or direct the clinical decisions and actions of physicians and dentists. The same summary says management companies may not participate in billing, coding, equipment selection, or clinical staff oversight in ways that influence physician judgment, and MSO agreements may not contain language that allows or implies investor or MSO influence over clinical judgment, staffing, medical records, or patient care decisions.
That means California is no longer satisfied with a structure that looks compliant only on paper. It is paying closer attention to whether the MSO is actually staying in a real administrative lane.
The Compensation Model Is Now A Major Red Flag
For PE-backed platforms, founder-led aesthetic groups, and management companies built around growth economics, compensation is often where the structure starts looking vulnerable.
The same California SB 351 summary explains that compliant MSO compensation must use a flat or fixed fee based on the fair market value of administrative services, and those fees must not be tied to clinical revenue, patient volume, or collections.
This is a major issue for older arrangements that were built around percentage-based management fees. From a business standpoint, those models may have felt efficient. From a 2026 California compliance standpoint, they now look much harder to defend.
If your MSO is still paid based on what the clinical side earns, the problem is no longer theoretical.
California Still Allows MSOs, But The Lane Is Much Narrower
SB 351 does not eliminate the MSO model. It limits what the management side can safely do and how it can be compensated.
An MSO can still support infrastructure, operations, and non-clinical functions. But once the management entity begins influencing physician staffing, shaping medical workflows through coding or billing pressure, or using contract language that gives the business side leverage over patient care decisions, the structure starts moving into dangerous territory.
This is where many businesses become uncomfortable. The model may have been built to centralize operations, move quickly, and scale efficiently. California is now forcing those businesses to ask whether the operating model still matches the legal model.
For businesses already working through MSO-PC design, this is exactly the kind of issue that now needs a second look.
Updating The Agreement Is Not Enough If The Real Structure Is Weak
Some businesses will treat SB 351 as a contract cleanup project. That is too narrow.
The California compliance overview recommends that businesses audit all MSO agreements immediately, remove language implying clinical control, restructure compensation to flat or fixed FMV-based fees, review investor and lender agreements for CPOM compliance, and strengthen telehealth protocols and medical director agreements.
That list is important because it shows California is looking beyond wording. If the agreement says the MSO only provides administrative services, but the day-to-day relationship suggests the business side is actually steering the practice, revised drafting alone will not solve the problem.
This is also why a strong Management Services Agreement in healthcare has to do more than list services. It has to reflect the real boundary between management support and medical authority.
AB 1415 Adds Another Layer Of Pressure
SB 351 is not the only California change affecting MSOs and investor-backed structures.
The same California 2026 summary covering AB 1415 explains that MSOs, private equity groups, and hedge funds are now treated as “noticing entities” under the Health Care Quality and Affordability Act. That means written notice to the Office of Health Care Affordability (OHCA) is required at least 90 days before certain material transactions, including mergers, acquisitions, affiliation agreements, and other major structural changes involving healthcare entities, including med spa practices.
That matters because California is not only tightening the rules. It is also creating more visibility into how these businesses are bought, sold, and restructured.
Enforcement Is No Longer A Background Concern
The California enforcement framework is much more serious than many businesses assume.
Under the same 2026 California summary, the Attorney General may seek injunctive relief and recover enforcement costs for violations. Physicians in non-compliant arrangements risk discipline from the California Medical Board, and MSOs or PE-backed entities may face civil liability and regulatory sanctions.
That changes the tone of the conversation. This is no longer about whether a structure feels common in the market. It is about whether it can survive California’s current enforcement environment.
What Should California Operators Be Reviewing Right Now?
If you are evaluating your structure, the most urgent questions are fairly straightforward. Is the MSO still being paid as a percentage of revenue, collections, or patient volume? Does the agreement imply control over staffing, medical records, or patient care? Does the management side influence billing, coding, equipment selection, or clinical supervision in ways that could affect physician judgment?
Do investor or lender agreements create indirect CPOM risk? Are telehealth protocols and medical director arrangements strong enough for California’s stricter 2026 posture? If the answer to any of those is yes, the structure deserves immediate attention.
The Wellness MD Group Angle
This is the practical takeaway for decision-makers: California is moving away from percentage-based MSO economics and toward a cleaner separation between management support and medical authority.
That means businesses need more than a physician name attached to the structure. They need agreements and operating models that reflect real separation, real oversight, and flat-fee FMV compensation instead of revenue participation.
For businesses trying to adjust quickly, this is where Wellness MD Group becomes relevant. We help restructure medical director and MSO-related relationships toward more defensible, flat-fee FMV-aligned models that fit the direction California is now demanding.
The Bottom Line
SB 351 does not automatically make every California MSO structure illegal. But it does make some older models much harder to defend.
If your arrangement still relies on percentage-based MSO fees, contract language implying clinical control, or a day-to-day operating model where the business side pushes too far into the medical side, California has given you a strong reason to act now.
The safest reading of 2026 is this: in California, a compliant MSO structure now needs to look more administrative, more clearly separated, and much less economically tied to clinical revenue than many legacy arrangements were built to be.
